Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in
national guidelines for bronchiectasis and is a major focus of drug development and clinical …

Pseudomonas aeruginosa is responsible for chronic infection in many bronchiectasis
patients but it is not known whether it is associated with worse clinical outcomes …

Introduction: Bronchiectasis is a chronic endobronchial suppurative disease characterized
by irreversibly dilated bronchi damaged by repeated polymicrobial infections and …

Bronchiectasis patients are susceptible to infection with Pseudomonas aeruginosa. Isolation
is associated with increased severity of disease, greater airflow obstruction and poorer …

Abstract Background An Expert Forum was held at the 2014 European Respiratory Society
International Congress to address issues involved in the management of Pseudomonas …

Objectives The objective of this study was to analyse lung function decline over time in
bronchiectasis, along with the factors associated with it. Methods Spirometry was measured …

Pseudomonas aeruginosa infection is associated with poorer outcomes in non-cystic fibrosis
bronchiectasis. It is unknown whether early eradication improves outcomes. This …

Background The hallmark of non-cystic fibrosis bronchiectasis is recurrent bronchial
infection, yet there are significant gaps in our understanding of pathogen persistence …

Rationale: Pseudomonas aeruginosa lung infection in patients with bronchiectasis, a
chronic airway disease that is characterized by episodes of exacerbation, is associated with …

Background The increasing prevalence and recognition of bronchiectasis in clinical practice
necessitates a better understanding of the economic disease burden to improve the …